Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention

JAC Antimicrob Resist. 2020 Aug 11;2(3):dlaa037. doi: 10.1093/jacamr/dlaa037. eCollection 2020 Sep.


OBJECTIVES: To evaluate the clinical impact of a bedside visit to patients with a positive Clostridioides difficile test on the antimicrobial stewardship of C. difficile infection (CDI) and non-C. difficile infections.

METHODS: All patients ≥18 years old with positive CDI laboratory tests hospitalized between January 2017 and August 2017 received an immediate bedside intervention that consisted mainly of checking protective measures and providing recommendations on infection control and the management of CDI and other infections.

RESULTS: A total of 214 patients were evaluated. The infectious disease (ID) physician was the first to establish protective measures in 25.2% of the cases. In 22/29 (75.9%) cases, physicians in charge accepted ID consultant recommendations to stop CDI treatment in asymptomatic patients. Unnecessary non-CDI antibiotics were discontinued in 19.1% of the cases. ID recommendations were not accepted by physicians in charge in only 12.6% of the cases.

CONCLUSIONS: A bedside rapid intervention for patients with a CDI-positive faecal sample was effective in avoiding overdiagnosis and unnecessary antibiotic treatment, optimizing anti-CDI drugs, increasing compliance with infection control measures and providing educational advice.

PMID:34223003 | PMC:PMC8210181 | DOI:10.1093/jacamr/dlaa037